Asia · Regional markets · CNBC-TV18
Tatva Chintan shares hit another 52-week high after reporting highest-ever quarterly turnover
Tatva Chintan Pharma said that it foresees the revenue trend growth with similar momentum over the next quarters and EBITDA margin.
Read the full article on CNBC-TV18 Sign in to saveMarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.cnbctv18.com)


